Trial Profile
A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR )
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Jan 2016
Price :
$35
*
At a glance
- Drugs Fomivirsen (Primary) ; Ganciclovir
- Indications Cytomegalovirus retinitis
- Focus Therapeutic Use
- Sponsors Ionis Pharmaceuticals
- 08 Jan 2016 New trial record